UCP1 and polycystic ovary syndrome: This was manifested as the synchronous double elevation of UCP1 and TH after EA treatment in PCOS-like rats, but only trends for an elevation after EA treatment in obese rats (Fig. 3A), indicating the possible major involvement of sympathetic stimulation of BAT in EA’s effect on PCOS, but not in the case of obesity.